Laura Brege Net Worth & Insider Trades
Laura Brege - Director, Mirum Pharmaceuticals, Inc
What is Laura Brege's Net Worth?
The current estimated net worth of Mirum Pharmaceuticals, Inc's Director, Laura Brege, is estimated to be about $7.24M . Laura Brege owns about 10,000 units of Mirum Pharmaceuticals, Inc common stock. In the last 3 years at Mirum Pharmaceuticals, Inc, Laura Brege has sold an estimated value of $0 worth.
What is Laura Brege's Past Insider Trading?
Laura Brege's largest purchase order was 10,000 units , worth over $112.2K on September 12, 2019. In total, Laura Brege has made about 5 transactions over 3 years of their time at Mirum Pharmaceuticals, Inc. Laura Brege usually trades in June, with the busiest year in 2019.
Laura Brege
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Laura Brege's' Mailing Address?
- Mailing address is C/o Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville CA 94608 CA
Mirum Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Christopher Peetz | 2020 | $511,818 | $265,952 | $2,218,755 | $7,453 | $3,003,978 |
| Christopher Peetz | 2019 | $457,614 | $286,100 | $5,491,471 | - | $6,235,185 |
| Peter Radovich | 2020 | $277,992 | $111,197 | $2,255,631 | - | $2,644,820 |
| Ian Clements, Ph.D. | 2020 | $378,390 | $151,356 | $848,348 | $11,400 | $1,389,494 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1759425/000119312521116249/d352758ddef14a.htm
What are Mirum Pharmaceuticals, Inc's Past Insider Trades?
Mirum Pharmaceuticals, Inc's most recent insider trade came on June 8, 2022 by James Flynn, Deerfield Mgmt Hif Lp, Deerfield Mgmt Iv Lp, Deerfield Management Company LP Series C, Deerfield Private Design Fund Iv Lp and Deerfield Healthcare Innovations Fund Lp who sold 38,478 units worth $962.26K . In the last 3 years, insiders at Mirum Pharmaceuticals, Inc have sold an estimated value of $3.82M and bought an estimated value of $113.81M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Ian Clements, Chief Financial Officer, Jonathan Edwin Tucker, Chief Medical Officer, and Christopher Peetz, President and CEO .
Mirum Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||